Potential predictive biomarker for diabetic peripheral neuropathy: serum neuron-specific enolase

Potential predictive biomarker for diabetic peripheral neuropathy: serum neuron-specific enolase

The early stages of diabetic peripheral neuropathy (DPN) are symptomless. A reliable dependable and sensitive biomarker is needed for the purpose of early identification of diabetic peripheral neuropathy. The main objective of the study was to evaluate the accuracy of serum neuron-specific enolase (...

Full description

Bibliographic Details
Main Authors:	Majeed Islam Fareed, Baban Rayah Sulaiman, Salman Isam Noori, AlRufaie Mohauman M.
Format:	Article
Language:	English
Published:	Sciendo 2023-12-01
Series:	Current Issues in Pharmacy and Medical Sciences
Subjects:	neuron-specific enolase diabetic peripheral neuropathy type 2 diabetes mellitus
Online Access:	https://doi.org/10.2478/cipms-2023-0039

Similar Items

Serum neuron-specific enolase as a biomarker in diagnosing diabetic peripheral neuropathy: A cross-sectional study
by: Sangeetha Kandasamy, et al.
Published: (2022-12-01)

The role of neuron specific enolase for endocrine ophthalmopathy and the formation of optic neuropathy
by: Vladimir Vyacheslavovich Charinzev, et al.
Published: (2016-03-01)

Promising predictors of diabetic peripheral neuropathy in children and adolescents with type 1 diabetes mellitus
by: Ahmed S. Abo Hola, et al.
Published: (2024-10-01)

Diagnostic Value of S100B and Neuron-specific Enolase in Distinguishing Acute Central and Peripheral Vertigo
by: Babak Masoumi, et al.
Published: (2022-12-01)

Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres
by: Jamie Burgess, et al.
Published: (2021-01-01)

Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management
by: Preston FG, et al.
Published: (2023-06-01)

Gender differences in Diabetic Peripheral Neuropathy
by: Mona Abosrea, et al.
Published: (2020-01-01)

High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy
by: Yu ZW, et al.
Published: (2020-04-01)

A clinical study on the application of diabetic neuropathy index for the diagnosis and staging of diabetic peripheral neuropathy
by: O Kwang-Chun, et al.
Published: (2019-01-01)

Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region
by: Georgios Ponirakis, et al.
Published: (2022-09-01)

A study on prevalence of diabetic peripheral neuropathy in diabetic patients attending a rural health and training centre
by: K Karthiksaravanan, et al.
Published: (2024-01-01)

Diabetes-induced peripheral neuropathy: Is prescribing physical exercise the answer?
by: Saghir Akhtar
Published: (2024-01-01)

A Pain Physician’s Perspective on Recent Advances in Painful Diabetic Peripheral Neuropathy Management
by: Pravesh Kanthed, et al.
Published: (2024-08-01)

Editorial: Early detection and combination therapy for diabetic peripheral neuropathy: what does the future look like?
by: Mark Yorek, et al.
Published: (2024-05-01)

Heart rate‐corrected QT interval: A novel diagnostic biomarker for diabetic peripheral neuropathy
by: Ai‐jun Jiang, et al.
Published: (2022-05-01)

Diabetic peripheral neuropathy - advances in diagnosis and treatment
by: Paula Bigos, et al.
Published: (2023-07-01)

Role of high-resolution ultrasonography in the evaluation of the tibial and median nerves in diabetic peripheral neuropathy
by: Ranjan Tanu, et al.
Published: (2022-10-01)

Peripheral Nerve Block in Patients with Diabetic Peripheral Neuropathy
by: WANG Jia
Published: (2022-11-01)

Hubungan Kadar Neuron-Specific Enolase Serum dengan Mortalitas pada Sepsis Neonatorum
by: Ricky Hartanto, et al.
Published: (2016-10-01)

Estimation of Apelin Levels in Iraqi Patients with Type II Diabetic Peripheral Neuropathy
by: Hadel Khalid Jaid, et al.
Published: (2023-10-01)

Serum neuron specific enolase is increased in pediatric acute encephalitis syndrome
by: Dian Pratamastuti, et al.
Published: (2017-09-01)

Prevalence in the Italian regions of pain in patients with diabetic peripheral neuropathy (NDP) and the current costs of drug treatment for principals with specific indication
by: Luca Guidi
Published: (2010-03-01)

Evaluation of efficacy of Amitriptyline vs. Gabapentin in diabetic peripheral neuropathy
by: Mala Chandra, et al.
Published: (2017-07-01)

Is there any relationship between vitamin D levels and the severity of diabetic peripheral neuropathy?
by: Rizaldy Taslim Pinzon, et al.
Published: (2020-06-01)

Use of neuron-specific enolase for assessing the severity and outcome of neurological disorders in patients
by: J.E. Lima, et al.
Published: (2004-01-01)

Application of toluidine blue stain and neuron specific enolase immunohistochemical stain in the diagnosis of hirschsprung disease
by: Tasmia Islam, et al.
Published: (2023-01-01)

Ultrasound features of diabetic peripheral neuropathy
by: Paloma E. Lopez-Delgadillo, et al.
Published: (2023-07-01)

Neuron specific enolase as a marker of the nervous system damage in primary hypothyroidism
by: Kuznetsova Е.В., et al.
Published: (2016-06-01)

status and insulin resistance in diabetic peripheral neuropathy
by: Taslima Akter, et al.
Published: (2016-12-01)

Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
by: Aslihan Abbasoglu, et al.
Published: (2015-04-01)

Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis
by: Hatem Hamed Elshorbagy, et al.
Published: (2019-12-01)

Non-Pharmacological Balance Therapy on Diabetic Peripheral Neuropathy Patients with Balance Disorders
by: Jeremy Nicolas Sibarani, et al.
Published: (2022-02-01)

Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer
by: Soh Maureen A, et al.
Published: (2011-11-01)

Correlation of nerve damage and peripheral neuropathy incidence using the MNSI and MDNS instrument approaches
by: Indah Nur Imamah, et al.
Published: (2024-01-01)

Rehabilitation Interventions for Gait Problems in Patients With Diabetic Peripheral Neuropathy: A Scoping Review
by: Charles Philip Gabel, et al.
Published: (2020-10-01)

The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey
by: Suayip Birinci, et al.
Published: (2023-09-01)

Screening for diabetic peripheral neuropathy in resource-limited settings
by: Ken Munene Nkonge, et al.
Published: (2023-03-01)

Application Progress of Ultrasound Elastography in the Evaluation of Diabetic Peripheral Neuropathy
by: Siqi Zheng, MM, Min Bai, MM
Published: (2024-03-01)

Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy?
by: Dalal Y. Al-Bazz, et al.
Published: (2022-03-01)

Valor da enolase específica do neurônio como indicador de prognóstico pós-parada cardiorrespiratória Serum neuron-specific enolase as a prognostic marker after a cardiac arrest
by: Tatiana H. Rech, et al.
Published: (2006-12-01)